BMRN vs LOGI · P/E 40, rev $1.76B vs P/E 22, rev $4.84B
Biomarin Pharmaceutical Inc (BMRN) versus Logitech International SA (LOGI) — a side-by-side from cached financials, not a winner call.
Biomarin Pharmaceutical Inc (BMRN) is a biotechnology company listed on NASDAQ.
Logitech International SA (LOGI) is a computer hardware company listed on US.
Latest reported BMRN revenue for 2026-06-30 was $1.76B. Net income was $150.3M. BMRN currently screens at market cap $10.63B and trailing P/E 39.6.
Latest reported LOGI revenue for 2026-03-31 was $4.84B. Net income was $711.2M. Revenue was up 6.3% from 2025-03-31 to 2026-03-31. LOGI currently screens at market cap $13.71B and trailing P/E 22.4.
BMRN currently screens at market cap $10.63B and trailing P/E 39.6. LOGI currently screens at market cap $13.71B and trailing P/E 22.4.
Not investment advice. Open the BMRN and LOGI stock pages for the full models.
Not investment advice.